https://orcid.org/0000-0001-5798-7692
References
- Shin Y, Park S, Lee JH. Clinical characteristics and medical utilization of smokers with preserved ratio impaired spirometry. J Chron Obstruc Pulmona Dis. 2023;2023:2187–2194. doi:10.2147/COPD.S425934
- Lavorini F. Commentary: quantifying bronchodilator responses in chronic obstructive pulmonary disease trials. Br J Clin Pharmacol. 2005;59(4):385–386. doi:10.1111/j.1365-2125.2005.02400.x
- Ozoh O, Eze J, Adeyeye O, et al. Unrecognized respiratory morbidity among adolescents and young adults in Nigeria: implications for future health outcomes. Niger Med J. 2020;61:210. doi:10.4103/nmj.NMJ_36_20
- Woodruff PG, Van Den Berge M, Boucher R, et al. American thoracic society_national heart, lung, and blood institute asthma-chronic obstructive pulmonary disease overlap workshop report. Am J Respir Crit Care Med. 2017;196(3):375–381. doi:10.1164/rccm.201705-0973WS
- Lamprecht B, Soriano JB, Studnicka M, et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest. 2015;148:971–985. doi:10.1378/chest.14-2535